Slingshot members are tracking this event:
Phase 3 MONARCH 2 Data Evaluating Abemaciclib in Patients with Relapsed/Refractory HR+/HER2- Breast Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Mar 20, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3 Data, Monarch 2 Study, Monarch 3 Study, Breast Cancer, Abemaciclib